Tolerance and efficacy of targeted therapies prescribed for off-label indications in refractory systemic autoimmune diseases: data of the first 100 patients enrolled in the TATA registry (TArgeted Therapy in Autoimmune Diseases)Jacques‐Eric Gottenberg, Xavier Mariette, Zahir Amoura et al.|RMD Open|2022Cited by 4
History of pre-eclampsia does not appear to be a risk factor for vascular phenotype in women with systemic sclerosisClaire de Moreuil, É. Hachulla, Elizabeth Diot et al.|RMD Open|2024Cited by 0